Fabry disease trials in Belgium

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

  Where

  Leuven

  Age

  2 years to 11 years

  People

  8 worldwide

  Run by

  Amicus Therapeutics

  See details and how to joinNCT06904261
• No phaseTaking people
  Fabry Disease Registry & Pregnancy Sub-registry

  Where

  Antwerp, Brussels, Leuven, Liège, Seraing

  People

  9,000 worldwide

  Run by

  Genzyme, a Sanofi Company

  See details and how to joinNCT00196742
• Phase 3Not yet taking people in Belgium
  An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subjects (aged 2 to < 12 years) with Fabry Disease and Amenable GLA Variants

  Where

  Leuven

  Age

  Up to 17 years

  People

  3 worldwide

  Run by

  Amicus Therapeutics Inc.

  See details and how to join2025-521244-38-00 · EU 2025-521244-38-00